MedPointe Acquires 100% Of Astelin® Rights In US And Canada
- [September 9, 2002]

MedPointe Announces Astelin® Co-Promotion Agreement with Sepracor
- [August 20, 2002]

MedPointe Announces Sale Of Wampole Laboratories
- [August 8, 2002]

MedPointe Announces Appointment Of Experienced Medical/Regulatory Affairs Executive, Richard N. Spivey, PharmD, PhD
- [July 1, 2002]

MedPointe Announces Corporate Relocation
- [May 28, 2002]

Paul R. Edick, Pharma Sales And Marketing Executive, Joins MedPointe As President-Wallace Pharmaceuticals
- [April 16, 2002]

Buyout Deal of the Year: MedPointe Inc. by The Carlyle Group and The Cypress Group
- [BuyoutsNewsletter.com, February 2002]

MedPointe: Seizing Opportunities in the Specialty Market
- [MedAd News, January 2002]

MedPointe Announces Sales Force Expansion,
Signs Agreement with Innovex - [January 14, 2002]
Total Wallace Rx Promotional Efforts to Exceed 300 Sales Representatives; Innovex to Provide Sales Force Recruitment and Training

Further inquiries should be directed to info@medapharma.us